DrugPatentWatch Database Preview
Drugs in Development Information for Pentastarch
Drug Development Status for Pentastarch: Sponsors, patents, clinical trial progress
Pentastarch is an investigational drug.
There have been 5 clinical trials for Pentastarch.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2009.
The most common disease conditions in clinical trials are Shock, Shock, Traumatic, and Shock, Hemorrhagic. The leading clinical trial sponsors are Sangart, Children's & Women's Health Centre of British Columbia, and Hamilton Health Sciences Corporation.
Summary for Pentastarch
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2009-02-01) |
| Vendors | 0 |
Recent Clinical Trials for Pentastarch
| Title | Sponsor | Phase |
|---|---|---|
| Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients | Sangart | Phase 2 |
| Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients | Sangart | Phase 2 |
| Fluid Resuscitation in Early Septic Shock | Baxter Healthcare Corporation | Phase 2 |
Clinical Trial Summary for Pentastarch
Top disease conditions for Pentastarch
Top clinical trial sponsors for Pentastarch
US Patents for Pentastarch
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
